glp-1 tirzepatide weight loss treatment colorado springs GLP-2 Medical Weight Loss & MMJ

The trial, conducted across multiple international sites and involving 725 adults living with obesity or overweight but without type 2 diabetes, concluded in April 2026 after 76 weeks of treatment

Certification Seals Independent programs such as NSF and USP may verify label claims, manufacturing controls and selected contaminants

If you want a deeper explanation of how these medications affect fullness, appetite, and digestion, this GLP-1 treatment guide is a useful next read

Batch-specific Certificates of Analysis (COAs) documenting analytical results

Diarrhea occurs in 10-30 percent of users, particularly at higher doses or when starting supplementation

Tesamorelin: Tesamorelin is a GHRH analog that stimulates natural growth hormone production and has FDA approval for reducing visceral adipose tissue in specific populations